Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz Sells 9,885 Shares

Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz sold 9,885 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total value of $810,273.45. Following the sale, the senior vice president now owns 18,835 shares of the company’s stock, valued at approximately $1,543,904.95. This trade represents a 34.42 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $82.36 on Friday. The business has a 50 day moving average price of $73.29 and a 200 day moving average price of $70.25. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $83.83. The company has a market cap of $4.07 billion, a price-to-earnings ratio of 20.04, a PEG ratio of 2.32 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. During the same quarter last year, the company earned $1.07 EPS. The company’s quarterly revenue was down .9% on a year-over-year basis. Research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Institutional Trading of Prestige Consumer Healthcare

Hedge funds have recently modified their holdings of the company. State Board of Administration of Florida Retirement System lifted its position in shares of Prestige Consumer Healthcare by 77.4% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after acquiring an additional 11,000 shares during the period. Lombard Odier Asset Management USA Corp acquired a new position in shares of Prestige Consumer Healthcare in the 2nd quarter worth approximately $550,000. CANADA LIFE ASSURANCE Co raised its holdings in shares of Prestige Consumer Healthcare by 19.4% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock worth $3,453,000 after buying an additional 7,715 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Prestige Consumer Healthcare by 12.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after buying an additional 1,120 shares in the last quarter. Finally, Atria Investments Inc acquired a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth approximately $1,246,000. Institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Jefferies Financial Group reiterated a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson restated a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $83.67.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.